bicalutamide

Bicalutamide (marketed as Casodex®, Cosudex®, Calutide®, Kalumid®) is an oral non-steroidal anti-androgen for prostate cancer. It was first launched in 1995 as a combination treatment (with surgical or medical castration) for advanced prostate cancer and subsequently launched as monotherapy for the treatment of earlier stages of the disease.
See more at Wikipedia.org...

Bicalutamide /bi·ca·lu·ta·mide/ an antiandrogen used in the treatment of prostatic carcinoma. bicalutamide Warning - Hazardous drug! Casodex [more]Bicalutamide - Community and Resources

[bye-ka-LOO-ta-mide]
An anticancer drug that belongs to the family of drugs called antiandrogens.